PCCA, founded in 1981, is a supplier serving independent compounding pharmacies. The company provides pharmaceutical chemicals, exclusive compounding bases, formula databases, professional-grade equipment, and ACPE-accredited educational programmes covering areas such as hormone replacement therapy, dermatology, and pain management. Its regulatory expertise spans USP 795, 797, and 800 compliance.
The firm supports more than 3,000 pharmacy members across the United States, Canada, Australia, and other countries. Its clinical staff bring over 500 years of combined experience in pharmaceutical compounding and clinical services.
PCCA also engages in advocacy work in Washington, D.C., aimed at ensuring continued patient access to compounded medications. The company's broader mission centres on enabling independent pharmacies to produce personalised medicine.
